SEC Form 4 · accession 0001493152-16-015978
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheela Mohan-Peterson
Officer — CL&CO
Period of report
Dec 14, 2016
Accepted (ET)
Dec 16, 2016 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F3,F2 | $8.80 | Dec 14, 2016 | D | 10,000 | D | — | Dec 16, 2024 | Common Stock | 10,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F4 | $7.60 | Dec 14, 2016 | D | 6,250 | D | — | Mar 3, 2025 | Common Stock | 6,250 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F5 | $5.76 | Dec 14, 2016 | D | 74,000 | D | — | Aug 21, 2025 | Common Stock | 74,000 | 0 | D |
| Employee Stock Option (right to buy)F1,F3,F6 | $1.29 | Dec 14, 2016 | A | 45,125 | A | — | Dec 14, 2026 | Common Stock | 45,125 | 45,125 | D |
Explanation of responses
- F1These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option.
- F2The stock options were scheduled to fully vest on December 16, 2017, the third anniversary of the grant date.
- F3On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its option exchange program, options for 10000 shares (previously granted on December 16, 2014), 6250 shares (previously granted on March 3, 2015) and 74000 shares (previously granted on August 21,2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 45125 shares of common stock with an exercise price of $1.29 per share.
- F4The stock options were scheduled to fully vest on March 3, 2018, the third anniversary of the grant date.
- F5The stock options were scheduled to fully vest on August 21, 2018, the third anniversary of the grant date.
- F6The stock options granted on December 14, 2016 will vest on the following schedule: 25% on grant date; 1/36th of the remaining 75% vesting on each of the 36 subsequent monthly anniversaries of the grant date.